Clinical trials
Lipid Metabolism Disorders trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 89bio, Inc. | 2 |
| Eli Lilly and Company | 2 |
| Katarzyna Siedzik | 1 |
| NewAmsterdam Pharma | 1 |
| Pfizer | 1 |
| Stanley Dudrick's Memorial Hospital | 1 |
| University of Warmia and Mazury in Olsztyn | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lipid Metabolism Disorders | 9 |
| Dyslipidemias | 6 |
| Metabolic Diseases | 5 |
| Hyperlipoproteinemias | 3 |
| Glucose Metabolism Disorders | 2 |
| Hypercholesterolemia | 2 |
| Hyperlipidemias | 2 |
| Hypertriglyceridemia | 2 |
| Atherosclerosis | 1 |
| Body Weight | 1 |
Trials
Showing 51 to 9 of 9. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.